Neuropsychopharmacology
- VTA-ACC dopaminergic circuit mediates trait anxiety-related observational learning of social avoidance in male mice6 months ago
- The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial6 months ago
- Prefrontal corticotropin-releasing factor promotes resilience to social stress6 months ago
- Sitagliptin as a therapeutic approach for social anxiety disorder: the role of DPP4 and NPY in modulating social fear and comorbid depressive-like behavior in mice6 months ago
- Merkel cell stimulation in fear and sensory signaling6 months ago
- Prelimbic cortical excitatory overdrive and inhibitory underdrive accompany environmental suppression of food seeking6 months ago
- One step at a time: use of single-session rTMS to test novel targets for substance use disorders6 months ago
Journal of Psychopharmacology
- Challenges for switching central nervous system and psychiatric medication products: A review of the literature10 months ago
- Systemic bupropion treatment reduces long-access cocaine self-administration in male and female rats10 months ago
- Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities11 months ago
- Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review11 months ago
- A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)11 months ago
- Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study11 months ago
- Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis11 months ago
European Neuropsychopharmacology
- Redefining schizophrenia treatment with muscarinic modulation—A perspective1 year ago
- Examining the impact of comorbid posttraumatic stress disorder on ketamine’s real-world effectiveness in treatment-resistant depression1 year ago
- Dilemmas in psychedelic medicine: From ethics to regulation and equity1 year ago
- Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia1 year ago
- Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study1 year ago
- Rare Genetic variation in schizophrenia: Are the most obvious ‘druggable pathways’ hiding in plain sight?1 year ago
- Valproate’s impact on future generations — A call for stricter guidelines for maternal and paternal use1 year ago